Clear definition of new drugs urged

Published: 2003-06-30 06:57:00

Updated: 2003-06-30 06:57:00

Domestic R&D based pharmaceutical firms have recently contended that more clear definition of new drugs and their license standards need to be re-established, as the current approval of Korean new drugs have been made via three different laws and regulation, such as Pharmaceutical Affairs Law, Na...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK